Literature DB >> 10566739

Relationship between serum leptin and fatty liver in Japanese male adolescent university students.

K Tobe1, T Ogura, C Tsukamoto, A Imai, K Matsuura, Y Iwasaki, H Shimomura, T Higashi, T Tsuji.   

Abstract

OBJECTIVE: The aim of this study was to elucidate the relationship between serum leptin levels and fatty liver in male adolescents.
METHODS: We investigated the relationship between the concentration of circulating leptin and fatty liver by measuring the serum concentration of leptin in 284 male students who received the matriculation health examination in Okayama University in 1996 (n = 197; age, 18-20 yr) or 1997 (n = 87; age, 18-20 yr).
RESULTS: Serum leptin levels correlated positively with body mass index (BMI), percent body fat (%FAT), thickness of skin fold (TSF), and serum concentration of ALT in 197 subjects. Examination of serum leptin in 67 subjects with BMI > or = 24.2 but < 28.6 kg/m2 showed a progressively higher levels in subjects with high serum ALT. Serum leptin levels in subjects with abnormally high serum ALT (> or = 37 IU/L) were significantly higher (p < 0.05) than in subjects with normal serum ALT, independent of BMI, %FAT, and TSF. Serum leptin levels were also significantly higher in subjects with fatty liver (detected by abdominal ultrasonography), independent of BMI and %FAT, compared with subjects without fatty liver. Stepwise multiple regression analysis showed that serum leptin level was an independent risk factor for fatty liver. In addition, serum leptin levels correlated with serum ALT (r = 0.518; p < 0.0005) and cholinesterase (r = 0.511; p < 0.0005) levels in 48 subjects with fatty liver.
CONCLUSIONS: Our results demonstrated that serum leptin concentrations are high in male adolescents with simple obesity and are associated with high serum ALT or fatty liver, independent of BMI and %FAT, suggesting that the concentration of circulating leptin correlates with fatty liver caused by accumulation of visceral fat.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10566739     DOI: 10.1111/j.1572-0241.1999.01549.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  7 in total

Review 1.  20 years of leptin: connecting leptin signaling to biological function.

Authors:  Margaret B Allison; Martin G Myers
Journal:  J Endocrinol       Date:  2014-10       Impact factor: 4.286

2.  Plasma leptin and TNF-alpha levels in chronic hepatitis C patients and their relationship to hepatic fibrosis.

Authors:  Javier Crespo; Montserrat Rivero; Emilio Fábrega; Amalía Cayón; José Antonio Amado; Maria Teresa García-Unzeta; Fernando Pons-Romero
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

Review 3.  Non-alcoholic fatty liver disease and the metabolic syndrome: an update.

Authors:  R Scott Rector; John P Thyfault; Yongzhong Wei; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

4.  The role of liver in leptin metabolism in experimental nephrotic syndrome.

Authors:  Dawoud Fakhry Habib; Abdelgawad Ali Fahmi; Naglaa Mohamed Kholousy; Ahmed Ibrahim Amin; Mostafa Shalaby; Mohamed Mahmoud Ahmed; Asem Metwally Abo Shanab
Journal:  EXCLI J       Date:  2011-12-19       Impact factor: 4.068

Review 5.  Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer.

Authors:  Yetirajam Rajesh; Devanand Sarkar
Journal:  Int J Mol Sci       Date:  2021-02-22       Impact factor: 5.923

Review 6.  Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.

Authors:  Un Ju Jung; Myung-Sook Choi
Journal:  Int J Mol Sci       Date:  2014-04-11       Impact factor: 5.923

7.  The association of fatty liver and diabetes risk.

Authors:  Masako Okamoto; Yasuhisa Takeda; Yoshioki Yoda; Kazuhisa Kobayashi; Masayuki A Fujino; Zentaro Yamagata
Journal:  J Epidemiol       Date:  2003-01       Impact factor: 3.809

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.